CLOs on the Move

WaferGen Biosystems

www.wafergen.com

 
WaferGen Bio-systems, Inc. is an innovative life science company that offers innovative genomic solutions for clinical testing and research. The SmartChip MyDesign(TM) Real-Time PCR System is a high-throughput genetic analysis platform for profiling and validating molecular biomarkers via microRNA and mRNA gene expression profiling, as well as single nucleotide polymorphism (SNP) genotyping. The SmartChip TE(TM) System is a novel product offering for target enrichment geared towards clinical Next-Gen sequencing (NGS). The Company now also offers the Apollo 324(TM) product line used in library preparation for NGS. These three complementary technologies offer a powerful set of tools enabling more accurate, faster ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.wafergen.com
  • 7400 Paseo Padre Pkwy
    Fremont, CA USA 94555
  • Phone: 510.651.4450

Executives

Name Title Contact Details

Similar Companies

Scientek Technology

Scientek Technology Corp. is a Delta, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Lab Water Purification System from Aqua Solutions

Lab Water Purification System from Aqua Solutions is a Jasper, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Tissue

Advanced Tissue is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Coeur Medical

Coeur Medical is a Washington, NC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Osiris Therapeutics

Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a significant impact. Difficult indications and challenging cases are targeted. Osiris has been studying tissue engineering since the beginning, and its dedicated team conducted groundbreaking research in the field. The work in bone led to the development of the successful product Osteocel, now owned by NuVasive Inc. Now, application of these technologies is being expanded beyond bone, to soft tissues, such as cartilage and tendon, and also wound healing.